l General Information |
Product Name | Difluprednate |
General description | Difluprednate is a synthetic difluorinated prednisolone derivative, it is originally developed for dermatologic applications. |
Synonym | CM 9155; difluoroprednisolone butyrate acetate; DFBA |
Purity | ≥99.0%(HPLC) | CAS Number | 23674-86-4 |
Formula | C27H34F2O7 | Molecular Weight | 508.559 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White or colorless Powder |
Solubility(25°C) | DMSO | ≥50mg/ml |
Ethanol | ≥5mg/ml |
Water | Very slightly soluble |
l Biological Information |
Biochem/Physiol
Actions | Difluprednate is a topical corticosteroid indicated for the treatment of infammation and pain associated with ocular surgery. It is a butyrate ester of 6(α), 9(α)-difluoro prednisolone acetate. Difluprednate is abbreviated DFBA, or difluoroprednisolone butyrate acetate. It is indicated for treatment of endogenous anterior uveiti. |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |